admission date:  [2112-4-28]              discharge date:   [2112-5-8]date of birth:  [2058-11-17]             sex:   mservice: surgeryallergies:kiwi (actinidia chinensis)attending:[first name3 (lf) 1384]chief complaint:hcc/hcv cirrhosis, liver failuremajor surgical or invasive procedure:liver [first name3 (lf) 1326] [2112-4-28]history of present illness:53 m diagnosed with hcc and hcv cirrhosis in [6-/2111], presentsfor olt. he was last seen by hepatology (dr [name (ni) ]) in[month (only) 404] at which time his meld was 28.past medical history:he was diagnosed with cirrhosis and hcc in [6-/2111] for which heunderwent cyberknife therapy in 6/[2111].  he has been listed forliver [year (4 digits) ] since 6/[2111]. he has had an egd at an osh in[2110-8-13] with grade 2 esophageal varices and portalhypertensive gastropathy.  he also had a colonoscopy in [month (only) 956][2110] which showed rectal varices.  he was last seen byhepatology on [2111-11-18] at which time his meld was 25 and hisdiurectics were increased for ongoing lower extremity edema.  hehas also had ongoing issues with poor sleep.social history:positive for etoh abuse but sober seven years. positive fortobacco. question of past cocaine use. lives alone. notcurrently working.family history:mother -  colon cancerfather -  esrdphysical exam:afebrile, vitals wnlgen - a&o x 3 nadpulm - ctabcv - rrr no m/g/rabd - +bs, nd, mild ttp near subcostal and midline incisionsextrem - no c/c/epertinent results:[2112-4-28]  wbc-5.3   hct-37.6  plt ct-92[2112-4-28]  wbc-12.9 hct-29.4  plt ct-105[2112-4-28]  wbc-21.7  hct-24.5  plt ct-77[2112-4-29]  wbc-14.7  hct-30.6  plt ct-89[2112-4-30]  wbc-14.4  hct-28.7  plt ct-78[2112-4-30]  wbc-19.2  hct-31.0  plt ct-72[2112-5-2]  wbc-14.3  hct-30.3  plt ct-81[2112-4-28] ptt-32.7 inr(pt)-1.3[2112-4-28] ptt-150 inr(pt)-3.1[2112-4-28] ptt-150 inr(pt)-2.9[2112-4-28] ptt-72.1 inr(pt)-2.2[2112-4-29] ptt-26.2 inr(pt)-1.3[2112-4-29] ptt-25.9 inr(pt)-1.2[2112-4-30] ptt-23.6 inr(pt)-1.1[2112-5-2] ptt-23.0 inr(pt)-1.0[2112-4-28] creat-0.8  na-139 k-3.7[2112-4-29] creat-1.5 na-137 k-4.0[2112-4-29] creat-1.6 na-138 k-4.1 cl-104[2112-4-30] creat-1.4 na-138 k-3.6 cl-102[2112-5-2] creat-0.8 na-135 k-4.2 cl-102[2112-4-28] alt-226 ast-303 alkphos-95 tbili-1.3[2112-4-28] alt-1444 ast-[2126] alkphos-51 amylase-33 tbili-2.4ld(ldh)-3050[2112-4-29] alt-1155 ast-1646 alkphos-52 tbili-2.6 dbili-1.9ibili-0.7[2112-4-29] alt-749 ast-727 alkphos-52 tbili-4.0[2112-4-30] alt-621 ast-501 alkphos-50 tbili-2.3[2112-5-1] alt-485 ast-253 alkphos-70 tbili-1.6[2112-5-2] alt-399 ast-122 alkphos-75 tbili-1.3 ld(ldh)-398[2112-5-3] alt-318 ast-105 alkphos-74 tbili-1.4[2112-5-4] alt-316 ast-110 alkphos-91 tbili-1.3[2112-5-5] alt-270 ast-118 alkphos-119 tbili-2.5[2112-5-6] alt-272 ast-92 alkphos-197 tbili-4.5[2112-4-29] pod 1 liver u/s - impression:1. status post liver [month/day/year ] with patent vasculature.2. 9-cm hematoma inferior to the porta hepatis and small amountof free fluid throughout the abdomen and pelvis.[2112-5-5] liver u/s: impression:1. status post liver [month/day/year ] with patent vasculature.2. two focal fluid collections adjacent to the left lateralsegment(measuring 3 cm) and inferior to the right lobe of the liver(measuringapproximately 1.4 cm) are noted.3. two echogenic structures within the transplanted liver mayrepresentsurgical clips versus calcifications and less likely pneumobiliaand are in  unchanged position compared to [2112-4-29].[5-6] ercp - impression:the [month/year (2) ] bile duct above the stricture was approximately5mm and the native cbd was approximately 8mm.given the small contrast leak at the anastomosis, balloondilation of the stricture was not performed.a sphincterotomy was performed in 12 o'clock position with asphincterotome successfully.a 10fr x 9cm advanix plastic biliary stent was placed across thestricture with excellent drainage of bile and contrast.brief hospital course:the patient was admitted to the [month/year (2) 1326] surgery service on[2112-4-28] and had an orthotopic liver [date range ]. surgeon was dr.[first name8 (namepattern2) ] [last name (namepattern1) 816]. please refer to operative note for further details.the patient tolerated the procedure well and was transferredintubated to the sicu for management. on pod 1 he was found tohave a large hematoma near the porta and was taken back to theor for washout and evacuation of the hematoma. this procedurewas also well tolerated.neuro: post-operatively, the patient received fentanyl &dilaudid iv with good effect and adequate pain control. whentolerating oral intake, the patient was transitioned to oralpain medications.cv: the patient was hypertensive on beginning pod 1 andinitially required hydralazine iv. once tolerating po he wasswitched to po norvasc and lopressor. the patient was otherwisestable from a cardiovascular standpoint; vital signs wereroutinely monitored.pulmonary: following extubation, the patient was stable from apulmonary standpoint; vital signs were routinely monitored.gi/gu: iv fluids were given until tolerating oral intake. hisdiet was advanced to clears on pod 3 and to a regular diet onpod 4, which was tolerated well. patient had lower extremityedema and rhonchi on auscultation. the lateral jp, located inthe hepatic/diaphragmatic gutter was discontinued on pod [5-3]and the medial jp, located near the porta hepatis wasdiscontinued on [5-8]. he was thought to be fluid oveloaded andon pod 3, 4, & 6 and was administered lasix iv. foley wasremoved on pod 4, once his fluid status had stabalized. intakeand output were closely monitored. the patients lft's increasedon pod 7&8 and he underwent an unremarkable liver u/s. on pod 8he had an ercp that showed a stricture and a small bile leak atthe cbd anastamosis. a plastic stent was placed by gi. thepatient tolerated the procedure well and his lft's trended downafter the procedure.endo: he experienced hyperglycemia from the steroids andrequired and insulin drip for several days. this wastransitioned to glargine and a humalog sliding scale per theconsulting [name8 (md) ] md. he was taught how to check his bloodglucose and how to draw up and administer insulin. vna serviceswere arranged to assist at home as insulin was new for him.id: post-operatively, the patient was started on bactrim,valcyte, and fluconazole for pcp, [name initial (nameis) 1074]/ebv, and [first name5 (namepattern1) 564] [last name (namepattern1) ]. thepatient's temperature was closely watched for signs ofinfection.immunosuppression: he received induction immunosuppression(solumedrol and cellcept). postop, solumedrol was taperedb bypost op day 6 to prednisone 20mg daily. cellcept 1 gram [hospital1 ] waswell tolerated. prograf was initiated on postop day 1 and doseadjusted per daily trough levels.prophylaxis: the patient received subcutaneous heparin duringthis stay, and was encouraged to get up and ambulate as early aspossible.at the time of discharge on pod [11-20], the patient was doingwell, afebrile with stable vital signs, tolerating a regulardiet, ambulating, voiding without assistance, and pain was wellcontrolled.pt cleared him for home. vna for medication (newly on insulin)was arranged.medications on admission:pantoprazole 40mg daily, nadolol 20mg daily, lasix 80mg daily,spironolactone 200mg daily, mvi, fish oildischarge medications:1. fluconazole 200 mg tablet sig: two (2) tablet po q24h (every24 hours).2. prednisone 5 mg tablet sig: four (4) tablet po daily (daily).3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2times a day).4. sulfamethoxazole-trimethoprim 400-80 mg tablet sig: one (1)tablet po daily (daily).5. mycophenolate mofetil 500 mg tablet sig: two (2) tablet pobid (2 times a day).6. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one(1) tablet, delayed release (e.c.) po daily (daily).7. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily).disp:60 tablet(s) refills:28. metoprolol tartrate 50 mg tablet sig: 1.5 tablets po bid (2times a day).disp:90 tablet(s) refills:29. tacrolimus  oral10. valganciclovir 450 mg tablet sig: two (2) tablet po daily(daily).11. oxycodone 5 mg tablet sig: 1-2 tablets po q4h (every 4hours) as needed for pain.disp:30 tablet(s) refills:012. insulin glargine 100 unit/ml solution sig: twenty nine (29)units subcutaneous once a day.disp:1 bottle refills:213. insulin lispro 100 unit/ml solution sig: follow slidingscale units subcutaneous four times a day.disp:1 bottle refills:214. tacrolimus  oral15. insulin lispro 100 unit/ml solution sig: follow slidingscale  units subcutaneous four times a day.disp:1 bottle refills:216. freestyle lite meter     kit sig: one (1) kit miscellaneousfour times a day.disp:1 kit refills:117. freestyle lite strips     strip sig: one (1)  miscellaneousfour times a day.disp:1 bottle refills:218. freestyle lancets     misc sig: one (1)  miscellaneous fourtimes a day.disp:1 box refills:219. insulin syringe-needle u-100 1 ml 26 x [2-14]  syringe sig: one(1)  miscellaneous four times a day: low dose syringes.disp:1 box refills:220. augmentin 875-125 mg tablet sig: one (1) tablet po twice aday for 7 doses.disp:7 tablet(s) refills:021. outpatient lab worklabs for am monday [5-9]: cbc, chem 10, lft's, tacrolimus level22. freestyle lite lancets and stripsdispense 2 boxes of sterile lancets and test strips for glucosemonitoring.  freestyle literefills: 2discharge disposition:home with servicefacility:[hospital 119] homecaredischarge diagnosis:hcchcv cirrhosisha anastomosis bleedinghyperglycemiadischarge condition:mental status: clear and coherent.level of consciousness: alert and interactive.activity status: ambulatory - independent.discharge instructions:please call the [hospital 1326] office [telephone/fax (1) 673] if you have anyof the following:fever, chills, nausea,vomiting, inability to take any of yourmedications, jaundice, increased abdominal/incision pain,incision redness/bleeding/drainage, constipation or diarrheayou will need to have blood drawn every monday and thursday at[last name (namepattern1) 439] lab on [location (un) 453]you may not drive while taking pain medication.no heavy lifting/strainingyou may shower with soap and water, but do not putpowder/ointment or lotion on your incisionfollowup instructions:provider: [name10 (nameis) ] [hospital 1389] clinic phone:[telephone/fax (1) 673]date/time:[2112-5-18] 11:20provider: [first name11 (name pattern1) 819] [last name (namepattern4) 820], md phone:[telephone/fax (1) 673] date/time:[2112-5-12]9:30provider: [first name11 (name pattern1) 674] [last name (namepattern4) 675], md phone:[telephone/fax (1) 673]date/time:[2112-5-19] 2:00provider: [first name11 (name pattern1) 674] [last name (namepattern4) 675], md phone:[telephone/fax (1) 673]date/time:[2112-5-26] 1:40